US Pharma MarketingSamsung Biologics: geographic diversification is a sound business decision
Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.
Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.
Source: Pharmaceutical Technology